logo

Breaking News

Share

digitalhealthinitiative jun05 The World Health Organization (WHO) and European Commission on Monday announced the launch of a landmark digital health partnership to strengthen global health security. In June 2023, WHO will take up the European Union (EU) system of digital COVID-19 certification to establish a global system that will help facilitate global mobility and protect citizens across the world from on-going and futu

Swiss pharma firm CSL Vifor, a subsidiary of Australia's CSL Ltd. (CSL.AX, CSLLY.PK), announced Monday that the U.S. Food and Drug Administration (FDA) has granted its partner American Regent, Inc., a Daiichi Sankyo Group company, approval for Injectafer for the treatment of iron deficiency in adult...

Cardinal Health, Inc. (CAH) announced Monday it has signed a definitive agreement to merge its Outcomes business to Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity. The combined organization...

CPI Card Group Inc. (PMTS), a payment technology firm, said on Monday that its Chief Executive Officer, Scott Scheirman, has informed of his intention to retire. Scheirman will continue to serve as CEO until a successor is named and intends to retire with effect from February 28, 2024. The company...

Aerospace company Barnes Group Inc. (B) announced Monday that it has entered into a definitive agreement to acquire MB Aerospace in deal valued at approximately $740 million. Upon closing of the transaction, MB Aerospace will become part of Barnes Aerospace. MB Aerospace is a leading provider of precision...

wallstreet 05jun23 Following the rally seen to close out the previous week, stocks may show a lack of direction in early trading on Monday. The major index futures are currently pointing to a roughly flat open for the markets, with the S&P 500 futures up by less than a tenth of a percent.

AstraZeneca PLC (AZN.L, AZN) and Daiichi Sankyo's Enhertu showed an objective response rate of 37.1% in the overall population of the DESTINY-PanTumor02 Phase II trial. An interim analysis of the trial showed that Enhertu demonstrated clinically meaningful and durable responses across a broad range of...

Chemomab Therapeutics Ltd. (CMMB), a company focused on fibrotic and inflammatory diseases, said on Monday that it has reappointed its former Chief Executive Officer and current Chief Scientific Officer, Adi Mor, as CEO. Mor will replace current CEO Dale Pfost. Sigal Fattal, former Chief Financial...

dominospizza jun05 Domino's Pizza Inc., the largest pizza company in the world, is offering customers 50 percent off all menu-priced pizzas ordered online today through June 11 ahead of summer. The weeklong 50 percent off online deal is available on menu-priced pizzas ordered through Domino's online ordering channels. These include www.dominos.com, Domino's mobile app, Amazon Alexa, Google Home, Facebook Messenger..

The U.S. Food and Drug Administration has lifted the clinical hold on the Phase 1 monotherapy dose escalation study of FHD-286 in acute myelogenous leukemia or AML and myelodysplastic syndrome or MDS, Foghorn Therapeutics Inc. (FHTX) said in a statement on Monday. In Monday pre-market trade, FHTX...

us pre market 053119 05jun23 The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.25 A.M. ET).

Bellerophon Therapeutics, Inc. (BLPH) reported top-line results from Phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for the treatment of fibrotic Interstitial Lung Disease. The trial did not meet its primary endpoint, related to the change in moderate to vigorous physical activity....

CIRCOR International, Inc. (CIR) announced Monday that it has entered into a definitive agreement to be acquired by investment funds managed by global investment firm KKR in an all cash transaction valued at approximately $1.6 billion, including the assumption of debt. Under the terms of the agreement,...

SpringWorks Therapeutics, Inc. (SWTX) announced the FDA has updated the PDUFA action date for the NDA for nirogacestat for the treatment of adults with desmoid tumors. The prior August 27, 2023 PDUFA date has been extended by three months. The FDA notified the company that it required more time to review...

The Canadian dollar advanced against its most major counterparts in the European session on Monday, as Saudi Arabia's decision to slash output by 1 million barrels per day lifted oil prices. Crude for July delivery rose $1.71 to 73.45 per barrel. Saudi Arabia announced extra output cuts from July...

Follow RTT